These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 29270001)

  • 41. [Effect of high doses of atorvastatin on the endothelial function of the coronary arteries].
    Simaitis A; Laucevicius A
    Medicina (Kaunas); 2003; 39(1):21-9. PubMed ID: 12576762
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Double-blind, randomized, prospective comparison of loading doses of 600 mg clopidogrel versus 60 mg prasugrel in patients with acute ST-segment elevation myocardial infarction scheduled for primary percutaneous intervention: the ETAMI trial (early thienopyridine treatment to improve primary PCI in patients with acute myocardial infarction).
    Zeymer U; Mochmann HC; Mark B; Arntz HR; Thiele H; Diller F; Montalescot G; Zahn R
    JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt B):147-154. PubMed ID: 25616919
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ticagrelor versus clopidogrel in real-world patients with ST elevation myocardial infarction: 1-year results by propensity score analysis.
    Vercellino M; Sànchez FA; Boasi V; Perri D; Tacchi C; Secco GG; Cattunar S; Pistis G; Mascelli G
    BMC Cardiovasc Disord; 2017 Apr; 17(1):97. PubMed ID: 28381298
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Therapeutic effects of different Atorvastatin doses on vulnerable plaques in coronary arteries assessed by intracoronary optical coherence tomography.
    Ye H; Wang S; Hu Y; He F; Ju J; Cui H; Chen X
    Medicine (Baltimore); 2018 Aug; 97(31):e11718. PubMed ID: 30075578
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of atorvastatin on reactive hyperemia and inflammatory process in patients with congestive heart failure.
    Tousoulis D; Antoniades C; Bosinakou E; Kotsopoulou M; Pitsavos C; Vlachopoulos C; Panagiotakos D; Stefanadis C
    Atherosclerosis; 2005 Feb; 178(2):359-63. PubMed ID: 15694946
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of atorvastatin and ezetimibe on endothelial function in dyslipidemic patients with chronic kidney disease.
    Ishimitsu T; Ohno E; Ueno Y; Onoda S; Nagase A; Ohira T; Nakano N; Satonaka H
    Clin Exp Nephrol; 2014 Oct; 18(5):704-10. PubMed ID: 24198051
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Atorvastatin has an important acute anti-inflammatory effect in patients with acute coronary syndrome: results of a randomized, double-blind, placebo-controlled study.
    Macin SM; Perna ER; Farías EF; Franciosi V; Cialzeta JR; Brizuela M; Medina F; Tajer C; Doval H; Badaracco R
    Am Heart J; 2005 Mar; 149(3):451-7. PubMed ID: 15864233
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Measurement of microvascular function in patients presenting with thrombolysis for ST elevation myocardial infarction, and PCI for non-ST elevation myocardial infarction.
    Palmer S; Layland J; Adams H; Ashokkumar S; Williams PD; Judkins C; La Gerche A; Burns AT; Whitbourn RJ; MacIsaac AI; Wilson AM
    Cardiovasc Revasc Med; 2018 Dec; 19(8):917-922. PubMed ID: 29709534
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Flow-mediated dilation in patients with coronary artery disease is enhanced by high dose atorvastatin compared to combined low dose atorvastatin and ezetimibe: results of the CEZAR study.
    Ostad MA; Eggeling S; Tschentscher P; Schwedhelm E; Böger R; Wenzel P; Meinertz T; Munzel T; Warnholtz A
    Atherosclerosis; 2009 Jul; 205(1):227-32. PubMed ID: 19150064
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association of endothelial dysfunction and no-reflow during primary percutaneous coronary intervention for ST-elevation myocardial infarction.
    Levi Y; Sultan A; Alemayehu M; Wall S; Lavi S
    Cardiovasc Revasc Med; 2016 Dec; 17(8):552-555. PubMed ID: 27638105
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of postprocedural full-dose infusion of bivalirudin on acute stent thrombosis in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: Outcomes in a large real-world population.
    Wang H; Liang Z; Li Y; Li B; Liu J; Hong X; Lu X; Wu J; Zhao W; Liu Q; An J; Li L; Pu F; Ming Q; Han Y
    Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28083915
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acute Myocardial Infarction: Changes in Patient Characteristics, Management, and 6-Month Outcomes Over a Period of 20 Years in the FAST-MI Program (French Registry of Acute ST-Elevation or Non-ST-Elevation Myocardial Infarction) 1995 to 2015.
    Puymirat E; Simon T; Cayla G; Cottin Y; Elbaz M; Coste P; Lemesle G; Motreff P; Popovic B; Khalife K; Labèque JN; Perret T; Le Ray C; Orion L; Jouve B; Blanchard D; Peycher P; Silvain J; Steg PG; Goldstein P; Guéret P; Belle L; Aissaoui N; Ferrières J; Schiele F; Danchin N;
    Circulation; 2017 Nov; 136(20):1908-1919. PubMed ID: 28844989
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-term mortality and prehospital tirofiban treatment in patients with ST elevation myocardial infarction.
    Fabris E; Kilic S; Schellings DAAM; Ten Berg JM; Kennedy MW; van Houwelingen KG; Giannitsis E; Kolkman E; Ottervanger JP; Hamm C; Van't Hof AWJ
    Heart; 2017 Oct; 103(19):1515-1520. PubMed ID: 28679686
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Peri-procedural tight glycemic control during early percutaneous coronary intervention up-regulates endothelial progenitor cell level and differentiation during acute ST-elevation myocardial infarction: effects on myocardial salvage.
    Marfella R; Rizzo MR; Siniscalchi M; Paolisso P; Barbieri M; Sardu C; Savinelli A; Angelico N; Del Gaudio S; Esposito N; Rambaldi PF; D'Onofrio N; Mansi L; Mauro C; Paolisso G; Balestrieri ML
    Int J Cardiol; 2013 Oct; 168(4):3954-62. PubMed ID: 23876463
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of atorvastatin on circulating hsCRP concentrations: a sub-study of the achieve cholesterol targets fast with atorvastatin stratified titration (ACTFAST) study.
    Gensini GF; Gori AM; Dilaghi B; Rostagno C; Gaw A; Blanco-Colio LM; de Teresa E; Egido J; Farsang C; Leiter LA; Martineau P; Nozza A; Langer A;
    Int J Cardiol; 2010 Jul; 142(3):257-64. PubMed ID: 19217176
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Assessment of the relation between initial culprit vessel patency in acute ST-elevation myocardial infarction and endothelial function.
    Kandhai-Ragunath JJ; Jørstad HT; de Wagenaar B; de Man FH; Stoel MG; van Es J; Doelman CJ; Doggen CJ; Peters RJ; von Birgelen C
    EuroIntervention; 2014 Nov; 10(7):784-91. PubMed ID: 25415147
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relative efficacy of atorvastatin 80 mg and pravastatin 40 mg in achieving the dual goals of low-density lipoprotein cholesterol <70 mg/dl and C-reactive protein <2 mg/l: an analysis of the PROVE-IT TIMI-22 trial.
    Ridker PM; Morrow DA; Rose LM; Rifai N; Cannon CP; Braunwald E
    J Am Coll Cardiol; 2005 May; 45(10):1644-8. PubMed ID: 15893181
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Relation of inflammatory markers with myocardial and microvascular injury in patients with reperfused ST-elevation myocardial infarction.
    Reindl M; Reinstadler SJ; Feistritzer HJ; Klug G; Tiller C; Mair J; Mayr A; Jaschke W; Metzler B
    Eur Heart J Acute Cardiovasc Care; 2017 Oct; 6(7):640-649. PubMed ID: 27440935
    [TBL] [Abstract][Full Text] [Related]  

  • 59. One-year Outcomes in Patients with ST-segment Elevation Myocardial Infarction Caused by Unprotected Left Main Coronary Artery Occlusion Treated by Primary Percutaneous Coronary Intervention.
    Liu HW; Han YL; Jin QM; Wang XZ; Ma YY; Wang G; Wang B; Xu K; Li Y; Chen SL
    Chin Med J (Engl); 2018 Jun; 131(12):1412-1419. PubMed ID: 29893357
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of atorvastatin on postcardiac transplant increase in low-density lipoprotein cholesterol reduces development of intimal hyperplasia and progression of endothelial dysfunction.
    See VY; DeNofrio D; Goldberg L; Chang G; Sasseen B; Kolansky DM; Pickering F; Kao A; Loh E; Wilensky RL
    Am J Cardiol; 2003 Jul; 92(1):11-5. PubMed ID: 12842237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.